1h Free Analyst Time
The next generation sequencing market is forecasted to grow by USD 3409.76 mn during 2022-2027, accelerating at a CAGR of 12.45% during the forecast period. The report on the next generation sequencing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increased utilization of NGS methods, growing demand for early diagnosis of genetic disorders, and availability of wide range of NGS products.
The next generation sequencing market is segmented as below:
By End-user
- Academic research
- Clinical research
- Pharma & biotech companies
- Others
By Product
- Consumables
- Equipment
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the next generation sequencing market covers the following areas:
- Next generation sequencing market sizing
- Next generation sequencing market forecast
- Next generation sequencing market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by End-user
7 Market Segmentation by Product
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global next generation sequencing market: 10X Genomics Inc., Azenta Inc., BGI Genomics Co. Ltd., Bio Rad Laboratories Inc., Eurofins Scientific SE, F. Hoffmann La Roche Ltd., Illumina Inc., Konica Minolta Inc., Laboratory Corp. of America Holdings, Merck KGaA, Nabsys Inc., OPKO Health Inc., Oxford Nanopore Technologies plc, Perkin Elmer Inc., PierianDx Inc., Psomagen Inc., QIAGEN NV, Standard BioTools Inc., Takara Bio Inc., and Thermo Fisher Scientific Inc..Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is advances in NGS techniques.'
According to the report, one of the major drivers for this market is the increased utilization of NGS methods.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 10X Genomics Inc.
- Azenta Inc.
- BGI Genomics Co. Ltd.
- Bio Rad Laboratories Inc.
- Eurofins Scientific SE
- F. Hoffmann La Roche Ltd.
- Illumina Inc.
- Konica Minolta Inc.
- Laboratory Corp. of America Holdings
- Merck KGaA
- Nabsys Inc.
- OPKO Health Inc.
- Oxford Nanopore Technologies plc
- Perkin Elmer Inc.
- PierianDx Inc.
- Psomagen Inc.
- QIAGEN NV
- Standard BioTools Inc.
- Takara Bio Inc.
- Thermo Fisher Scientific Inc.